Email address: carles.vilarino-guell@ubc.ca
Research Summary: We implement second generation sequencing technologies for the identification of mutations causing highly prevalent neurological diseases, with primary focus on multiple sclerosis, and characterize new models of human disease based on these discoveries for the development of novel and more effective treatments.
Website: https://msgeneticslab.med.ubc.ca/